ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0020094 | A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC). | Leukemia Virus I, Human T-Cell|human t-lymphotropic virus 1|T-Cell Leukemia Virus I, Human|Human T lymphotropic virus 1|Virus-HTLV-I|Human T-Lymphotropic Virus, Type I|Human T-Lymphotropic Virus 1|human i t lymphotropic type virus|human T lymphotropic virus I|Human T-cell leukemia virus type 1|human T-cell leukemia virus type 1|T Cell Leukemia Virus I, Human|HTLV I|htlv 1|HTLV-1 - Human T-cell lymphotropic virus type 1|Human T-cell lymphotropic virus type 1|Human T-lymphotropic virus, type I|Leukemia Lymphoma Virus I, Adult T Cell|HTLV-1|Leukemia Virus I, Human T Cell|Human T-lymphotropic virus 1 (organism)|HTLV-I|Human T Cell Leukemia Virus I|Adult T Cell Leukemia Lymphoma Virus I|human T cell lymphoma virus I|htlv-i|human T-cell lymphotropic virus type 1|human T cell leukemia virus I|htlv-1|htlv i|Human T-lymphotropic virus 1|Adult T-cell Lymphoma Virus Type 1|HUMAN T-LYMPHOTROPIC VIRUS 1|Adult T-Cell Leukemia-Lymphoma Virus I|Human T-cell leukaemia virus type 1|Adult T-cell Leukemia Lymphoma ATLL|human T cell lymphotropic virus type 1|Human T-Cell Leukemia Virus I|ATLV | Human T-lymphotropic virus 1 |
C1336745 | A lymphoma that arises from the thymus. Representative examples include mediastinal (thymic) large B-cell lymphoma and Hodgkin lymphoma. | Lymphoma of Thymus|Thymus Lymphoma|Primary Thymic Lymphoma|Lymphoma of the Thymus | Thymic Lymphoma |
C0543421 | null | total cholesterol|cholesterol total | Total cholesterol |
C1287242 | null | antibody titers|Antibody titer|antibody titres|Antibody titer - finding|Finding of antibody titer (finding)|Finding of antibody titer|antibody titer|antibody titre|antibodies titre|Finding of antibody titre|Antibody titre|Antibody titre - finding | Finding of antibody titer |
C0299792 | A quinoline derivate and atypical anti-psychotic agent. Aripiprazole has partial agonistic activity at dopamine D2 receptors and serotonin 5-HT1A receptors, as well as potent antagonistic activity on serotonin 5-HT2A receptors. This drug stabilizes dopamine and serotonin activity in the limbic and cortical system. Aripiprazole is used in managing symptoms of schizophrenia and of acute manic and mixed episodes associated with bipolar I disorders. | Product containing aripiprazole (medicinal product)|Aripiprazole-containing product|Aripiprazole|ARIPIPRAZOLE|aripiprazole|Aripiprazole (substance)|ARIPiprazole|2(1H)-Quinolinone, 7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-|7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone|Aripiprazol|Aripiprazolum | aripiprazole |
C0001889 | A syndrome characterized by a silent and inert state without voluntary motor activity despite preserved sensorimotor pathways and vigilance. Bilateral FRONTAL LOBE dysfunction involving the anterior cingulate gyrus and related brain injuries are associated with this condition. This may result in impaired abilities to communicate and initiate motor activities. (From Adams et al., Principles of Neurology, 6th ed, p348; Fortschr Neurol Psychiatr 1995 Feb;63(2):59-67) | coma vigil|Autism, Akinetic|Akinetic mutism (disorder)|vigil coma|Coma vigil|Akinetic mutism|Coma vigilans|Akinetic autism|Akinetic Autism|Akinetic Mutisms|Vigils, Coma|Akinetic Mutism|Agrypnodal coma|Mutism, Akinetic|Coma Vigil|mutism akinetic|AKINETIC MUTISM|akinetic mutism|Vigil, Coma|Coma, vigil|Coma Vigilans | Akinetic Mutism |
C1160466 | The formation of one or more covalent or non-covalent links between two or more chemical compounds. | Chemical Conjugation|conjugation|Conjugation | Chemical Conjugation |
C0023768 | Layers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes. | Bilayer, Lipid|Lipid Bilayer|Lipid bilayer|Bilayer lipid membranes|lipid bilayer|Bilayers, Lipid|lipid bilayer membrane | Lipid Bilayers |
C0012582 | A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) | Dipyridamole|Dipyridamole-containing product|2,2',2'',2''''-[(4,8-Dipiperidinopyrimido-[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetraethanol|DIPYRIDAMOLE|Dipyridamolum|Dipyridamine|Product containing dipyridamole (medicinal product)|Dipyridamole (substance)|dipyridamole|DP|Dipyramidole|Dypyridamol|dipyramidole|Dipiridamol|Dipyudamine|Ethanol, 2,2',2'',2'''-((4,8-di-1-piperidinylpyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis- | dipyridamole |
C0039663 | A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. | 9 ene Tetrahydrocannabinol|delta(1)-THC|Delta-9-THC|1-trans-delta-9-Tetrahydrocannabinol|Delta9-THC|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol|Δ9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol|delta(9)-Tetrahydrocannabinol|dronabinol|Delta-9-tetrahydrocannabinol|Delta-9-Tetrahydrocannabinol|delta(1)-tetrahydrocannabinol|6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-|6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|delta 9-tetrahydrocannabinol|Tetrahydrocannabinol|(-)-.DELTA.9-Tetrahydrocannabinol|tetrahydrocannabinol|Dronabinol (substance)|Dronabinolum|tetrahydrocannabinol (THC)|delta9-tetrahydrocannabinol|delta(9)-THC|Synthetic delta-9-Tetrahydrocannabinol|Product containing dronabinol (medicinal product)|Tetrahydrocannabinol (substance)|delta-9-Tetrahydrocannabinol|delta(1)-Tetrahydrocannabinol|Delta 9-Tetrahydrocannabinol|9-ene-Tetrahydrocannabinol|Delta-9-tetrahydrocannabinol (substance)|Dronabinol-containing product|DRONABINOL|Dronabinol|(-)-delta9-trans-Tetrahydrocannabinol|Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol|delta-9-THC|Delta(9)-Tetrahydrocannibinol|THC | dronabinol |
C0002771 | Compounds capable of relieving pain without the loss of CONSCIOUSNESS. | Analgesics|pain relieving drugs|Pain Relievers|anodyne|Drugs, Analgesic|Medicinal product acting as analgesic agent (product)|ANALGESICS|pain killer drug|Painkillers|analgesic drugs|analgesics drug|Analgesic Agent|Analgesic agent|Analgesic|Pain medicines|Analgesic (substance)|Analgesic Agents|analgesics|analgesic drug|Analgesic Drugs|Pain-relief Medication|Pain killers|Analgesic Preparation|Anodynes|analgesics drugs|Agents, Analgesic|analgesic|analgesic agents|anodynes|Analgesic, NOS | Analgesics |
C0016556 | The application of dental knowledge to questions of law. | dentistry forensic|Dentistry, Forensic|forensic dentistry | Forensic Dentistry |
C0011443 | The teeth collectively in the dental arch. Dentition ordinarily refers to the natural teeth in position in their alveoli. Dentition referring to the deciduous teeth is DENTITION, PRIMARY; to the permanent teeth, DENTITION, PERMANENT. (From Jablonski, Dictionary of Dentistry, 1992) | Dentition|dentition|Dentition (body structure)|Dentitions | Dentition |
C0006779 | The measurement of the quantity of heat involved in various processes, such as chemical reactions, changes of state, and formations of solutions, or in the determination of the heat capacities of substances. The fundamental unit of measurement is the joule or the calorie (4.184 joules). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) | calorimetry|Calorimetry|Calorimetry (procedure) | Calorimetry |
C0269202 | A cyst in the uterine cervix. | cervical cyst|Cyst of the Cervix Uteri|Cyst of Cervix|Cervical Cyst|cervix cysts|CERVICAL CYST|Cyst of Cervix Uteri|Cyst of the Cervix|cyst of cervix|Cyst of the Uterine Cervix|cyst cervix|cervix cyst|Cervical cyst|Cyst of Uterine Cervix|cervical cysts|Cyst of cervix (disorder)|Cervix Cyst|Cyst of cervix|Uterine Cervix Cyst|Cervix Uteri Cyst|cyst cervical | Cyst of cervix |
C1514725 | null | null | Rare Lesion |
C0025252 | Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. | Membrane proteins|Protein, Membrane|Membrane Protein|Proteins, Membrane|surface proteins|Surface Proteins|membrane protein|Membrane-Associated Proteins|Proteins, Membrane-Associated|surface protein|membrane proteins|protein surface|Proteins, Surface|Membrane Associated Proteins | Membrane Proteins |
C0684331 | null | prosecutions|Imprisonment|Litigation|litigation|Prosecution|imprisonment|prosecution | Litigation affecting health status |
C0008073 | Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed) | Developmental disorder, NOS|Developmental disorder|Developmental Disability|DEVELOPMENTAL DISORDERS|developmental disabilities|child development disorders|Development Disorder, Child|Developmental Disorder|developmental delay disorders|Developmental disorder (disorder)|Disability, Developmental|Developmental Disabilities|child development disorder|Developmental disabilities|developmental disability|Child Development Disorder|Development Disorders, Child|Developmental disorder NOS|Child Development Disorders|developmental disorders|developmental disorder|child developmental disabilities|Disabilities, Developmental|Developmental disability | Developmental Disabilities |
C0025355 | Organized services to provide mental health care. | Hygiene Service, Mental|Service, Mental Hygiene|Mental health services|Health Services, Mental|mental health services|Services, Mental Health|Hygiene Services, Mental|health mental services|Mental health services, not otherwise specified|Mental Health Service|Service, Mental Health|Health Service, Mental|Mental Hygiene Service|mental health service|Services, Mental Hygiene|Mental health service|Mental health service (qualifier value)|Mental Hygiene Services | Mental Health Services |
C0233558 | null | Temper tantrum (finding)|Temper tantrums|Temper Tantrums|tantrums|tantrum|temper tantrums|tantrums temper|temper tantrum|Tantrums | Temper tantrum |
C0344460 | A carcinoma arising in a pre-existing pleomorphic adenoma. It most often occurs in the parotid gland and less often in the submandibular gland and minor salivary gland. Patients usually present with a history of a long-standing mass which recently had undergone rapid growth. The prognosis depends on the invasiveness of the malignant component. Patients with non-invasive or minimally invasive tumors usually have a good prognosis following surgical resection. Invasive tumors are usually aggressive and are associated with recurrences and metastases. | Carcinoma in pleomorphic adenoma|Carcinoma in Pleomorphic Adenoma|Carcinoma ex Pleomorphic Adenoma|Carcinoma ex pleomorphic adenoma (morphologic abnormality) | Carcinoma ex pleomorphic adenoma |
C0554011 | Surgery involving excision of the superficial portion of the parotid gland. | superficial parotidectomy|Superficial parotidectomy (procedure)|Superficial Parotidectomy | Superficial parotidectomy |
C0596392 | refers to the bones of the skull and face. | craniofacial | craniofacial |
C0033045 | Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. | premedications|pre-med|Premedications|pres meds|pre meds|premedication | Premedication |
C0524861 | Surgical procedures used to treat disease, injuries, and defects of the oral and maxillofacial region. | surgical procedures oral|Oral Surgical Procedure|Procedure, Oral Surgical|Surgical Procedure, Oral|Surgical Procedures, Oral|oral surgery|surgery oral|oral surgeries|Procedures, Oral Surgical|Oral Surgical Procedures | Oral Surgical Procedures |
C0083381 | An oxicam derivative and a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, antipyretic and analgesic activities. Unlike traditional nonselective NSAIDs, meloxicam preferentially inhibits the activity of cyclo-oxygenase II (COX-II), resulting in a decreased conversion of arachidonic acid into prostaglandin precursors. The resulting decrease in prostaglandin synthesis is responsible for the therapeutic effects of meloxicam. | Miloxicam|miloxicam|4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide|Meloxicam|Meloxicam (substance)|Méloxicam|Meloxicam-containing product|Meloxicamum|meloxicam|2H-1,2-Benzothiazine-3-carboximidic acid, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide|Product containing meloxicam (medicinal product)|MELOXICAM | meloxicam |
C0030201 | Pain during the period after surgery. | pain post-operative|Pain, Postoperative|Postoperative Pain|post-op pain|Postoperative pain (finding)|Post Surgery Pain|post-operative pain|Postoperative pain|postoperative pain|postoperative pains|pain postoperative|Postoperative pain NOS|Postoperative Pains|Post-Operative Pain|pain post op|pain post-op | Pain, Postoperative |
C0002921 | A blocking of nerve conduction to a specific area by an injection of an anesthetic agent. | Local anaesthesia|anaesthesia local|local anesthetic|Local anaesthesia, NOS|anaesthetics local|anesthetic local techniques|Local anaesthetic technique|Anesthesia, Local|Local Anesthesia|Local anesthetic technique|Local Anesthesia Procedure|anesthetic local procedure|local anesthetic technique|Local anesthesia|Local anaesthetic|local anaesthetic|anesthetic local|Local anesthetic|local anesthesia|laing|Local anesthesia (procedure)|local anesthesia procedure|local anaesthesia|anesthesia local|Local anesthesia, NOS|anaesthetic local | Local anesthesia |
C0065199 | null | 2-(4-((2-oxocyclopentyl)methyl)phenyl)propionic acid|Loxoprofen|2-OCPPP|LOXOPROFEN|Loxoprofen (substance)|Loxoprofene|loxoprofen|Loxoprofeno|Loxoprofenum | loxoprofen |
C0032474 | Polymers of organic acids and alcohols, with ester linkages--usually polyethylene terephthalate; can be cured into hard plastic, films or tapes, or fibers which can be woven into fabrics, meshes or velours. | polyester|Polyester|Polyester (substance)|Polyester, NOS|Polyesters | Polyesters |
C0032502 | A biocompatible polymer used as a surgical suture material. | POLYGLYCOLIC ACID|Poly(oxy(1-oxo-1,2-ethanediyl))|Polyglycolide | Polyglycolic Acid |
C0085106 | An autosomal dominantly inherited skin disorder characterized by recurrent eruptions of vesicles and BULLAE mainly on the neck, axillae, and groin. Mutations in the ATP2C1 gene (encoding the secretory pathway Ca2++/Mn2++ ATPase 1 (SPCA1)) cause this disease. It is clinically and histologically similar to DARIER DISEASE - both have abnormal, unstable DESMOSOMES between KERATINOCYTES and defective CALCIUM-TRANSPORTING ATPASES. It is unrelated to PEMPHIGUS VULGARIS though it closely resembles that disease. | Familial Pemphigus, Benign|Familial Benign Pemphigus|Hailey-Hailey Disease|Benign Chronic Pemphigus|PEMPHIGUS, BENIGN FAMILIAL|Hailey-Hailey disease|hailey hailey disease|hailey disease|Hailey Hailey Disease|hailey-hailey disease|Benign Familial Pemphigus|Chronic Benign Familial Pemphigus|Pemphigus, Benign Familial|HHD|Hailey Hailey disease|Familial benign pemphigus (disorder)|Benign familial chronic pemphigus|BCPM|HAILEY-HAILEY DISEASE|Familial benign pemphigus|Familial Benign Chronic Pemphigus|Familial benign chronic pemphigus|BENIGN CHRONIC PEMPHIGUS|benign familial pemphigus|diseases hailey hailey | Familial benign pemphigus |
C0493436 | Campylobacter fetus serological reagents are devices that consist of antisera conjugated with a fluorescent dye used to identify Campylobacter fetus from clinical specimens or cultured isolates derived from clinical specimens. The identification aids in the diagnosis of diseases caused by this bacterium and provides epidemiological information on these diseases. Campylobacter fetus is a frequent cause of abortion in sheep and cattle and is sometimes responsible for endocarditis (inflammation of certain membranes of the heart) and enteritis (inflammation of the intestines) in humans. | null | CAMPYLOBACTER SPP. |
C0008809 | A broad-spectrum antimicrobial carboxyfluoroquinoline. | 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid|ciprofloxacin|3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-|Ciprofloxacin-containing product|1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid|CIPROFLOXACIN|1-cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid|Ciprofloxacine|1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid|1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid|Ciprofloxacino|Ciprofloxacin (substance)|CPFX|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid|Product containing ciprofloxacin (medicinal product)|Ciprofloxacinum|Ciprofloxacin|1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid | ciprofloxacin |
C0596846 | The directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Lipids are compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. [ISBN:0198506732] | lipid transport|Lipid Trafficking | Lipid Transport |
C0030940 | Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES. | Proteinase|Proteolytic enzyme|peptide hydrolases|Proteases|peptide hydrolase|Proteolytic Enzymes|peptidases|Proteinases|PROTEOLYTIC ENZYME|Protease|Peptide Hydrolase|proteolytic enzymes|Peptidases|enzymes proteolytic|proteolytic|Substance with peptide hydrolase mechanism of action (substance)|Peptidase|Proteolytic Enzyme|Proteolytic enzymes|Peptide hydrolase|Esteroproteases|Substance with peptide hydrolase mechanism of action|Peptide Hydrolases|proteolytic enzyme|peptidase | Peptide Hydrolases |
C0038126 | Stainless steel. A steel containing Ni, Cr, or both. It does not tarnish on exposure and is used in corrosive environments. (Grant & Hack's Chemical Dictionary, 5th ed) | Stainless steel material|Steels, Stainless|Stainless steel|stainless steel|Stainless Steels|Stainless steel material (substance)|Steel, Stainless|SS - Stainless steel | Stainless Steel |
C0034552 | Liquid, solid, or gaseous waste resulting from mining of radioactive ore, production of reactor fuel materials, reactor operation, processing of irradiated reactor fuels, and related operations, and from use of radioactive materials in research, industry, and medicine. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) | Wastes, Radioactive Hazardous|Radioactive Hazardous Wastes|Radioactive Wastes|Hazardous Wastes, Radioactive|Radioactive wastes|Radioactive Hazardous Waste|Waste, Nuclear|Hazardous Waste, Radioactive|nuclear waste|radioactive waste|Nuclear Waste|Waste, Radioactive Hazardous|Wastes, Nuclear|Nuclear Wastes|Waste, Radioactive|Wastes, Radioactive | Radioactive Waste |
C0022885 | Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting. | Laboratory procedure (procedure)|Test|Laboratory procedures -general (situation)|Laboratory test (procedure)|lab tests|lab test|General laboratory procedure, NOS|Laboratory procedure|Laboratory Procedures|laboratory testing|labs testing|Laboratory test, NOS|General Laboratory Procedures|Laboratory test|GENERAL LABORATORY PROCEDURES AND SERVICES|Laboratory Procedure|Laboratory (CMS Temporary Codes)|Laboratory procedures -general|laboratory tests|labs test|laboratory procedures|Lab Tests|Laboratory procedures|Laboratory Test|Laboratory Tests|LABORATORY PROCEDURES AND SERVICES|laboratory procedure|General laboratory procedure|Lab Test|laboratory test|lab testing|Tests | Laboratory Procedures |
C0004914 | That which comprises the place where a subject sleeps. | BEDDING|bedding|Bedding (physical object)|Bedding Material|Beddings|Bedding | Bedding |
C1510451 | null | Fries|Chipped potatoes|French fries|French fries (substance)|Chips | French fries |
C0450363 | The property of being measured and described using three orthogonal directions. | 3 dimensional|three dimensional|three-dimensional|3-dimensional|3-Dimensional|Three-dimensional (qualifier value)|3D|3D - Three-dimensional|Three-dimensional|3-D | Three-dimensional |
C0242842 | A light microscopic technique in which only a small spot is illuminated and observed at a time. An image is constructed through point-by-point scanning of the field in this manner. Light sources may be conventional or laser, and fluorescence or transmitted observations are possible. | Confocal microscopy|CONFOCAL MICROSCOPY|Confocal Microscopy|confocal microscopy|Microscopies, Confocal|Confocal Microscopies|Microscopy, Confocal|Confocal Laser Scanning Microscopy | Microscopy, Confocal |
C0600364 | The coupling of a biological material (for example, enzyme, receptor, antibody, whole cell, organelle) with a microelectronic system or device to enable rapid, accurate, low level detection of various substances in body fluids, water, and air. | biosensor|sensor (biological)|Biosensors|Biosensor|biosensors | Biosensors |
C0429693 | null | maximum oxygen uptake|Maximum oxygen uptake (observable entity)|VO2 - Maximum oxygen uptake | Maximum oxygen uptake |
C0005106 | Toluenes in which one hydrogen of the methyl group is substituted by an amino group. Permitted are any substituents on the benzene ring or the amino group. | Benzylamines|benzylamine | Benzylamines |
C0656016 | null | beta Tryptases|beta-Tryptase|Beta tryptase (substance)|beta Tryptase|beta tryptase|Beta tryptase | beta-Tryptases |
C0012937 | Circular duplex DNA isolated from viruses, bacteria and mitochondria in supercoiled or supertwisted form. This superhelical DNA is endowed with free energy. During transcription, the magnitude of RNA initiation is proportional to the DNA superhelicity. | DNA, Supertwisted|Supertwisted DNA|Superhelical DNA|DNA, Supercoiled|Supercoiled DNA | DNA, Superhelical |
C0031740 | Therapy using oral or topical photosensitizing agents with subsequent exposure to light. | Photoradiation Therapy|therapy, photodynamic|Photodynamic Therapies|photodynamic therapy|Photochemotherapy, NOS|Therapy, Photodynamic|Photochemotherapy|neoplasm/cancer photoradiation therapy|photochemotherapy|Photochemotherapy (procedure)|Photodynamic therapy|Photochemotherapies|Photodynamic Therapy|Therapies, Photodynamic|PDT|Photodynamic therapy (procedure)|PDT - Photodynamic therapy | Photochemotherapy |
C0060819 | null | Fumagillin|fumagillin|FUMAGILLIN|Fumagillin (substance) | fumagillin |
C0017319 | Physicians whose practice is not restricted to a specific field of MEDICINE. | Practitioner, General|Physicians, General Practice|General Practice Physician|General Practice Physicians|General Practitioner|Practitioners, General|gp|General practioner|general practitioner|GP|General physician, NOS|Physician, General Practice|Practice Physicians, General|general practitioner (GP)|General practitioner|GP - General practitioner|general practice physician|generalist|Physicians (General practice)|General physician|General physician (occupation)|general physician|general practitioners|General Practitioners | General Practitioners |
C1265769 | null | multiple aneurysms|Multiple aneurysms|Multiple aneurysms (morphologic abnormality)|multiple aneurysm | Multiple aneurysms |
C0340639 | null | aneurysms artery carotid|Carotid artery aneurysm (disorder)|Aneurysm of carotid artery|Carotid artery aneurysm|aneurysm carotid artery|carotid artery aneurysm | Carotid artery aneurysm |
C0262428 | null | COLLAGEN VASCULAR DISEASE|collagen diseases vascular|vascular disease collagen|vascular collagen disease|collagen vascular disease|collagen vascular diseases|COLLAGEN/VASCULAR DISEASE|collagen-vascular disease|collagen disease vascular | Collagen-vascular disease |
C0232339 | null | Normal blood flow|Vascular flow, normal|Normal vascular flow|Normal vascular flow (finding) | Normal vascular flow |
C0180236 | A spoon-shaped instrument with a sharp edge. | CURETTE|Curette|curette|curetting|curet|Curette (physical object)|curetted|curettes|Curettes|cureting | Curette |
C0277562 | null | adults diseases|disease adult|adults disease|adult disease|adult diseases|Adult disease (finding)|Adult disease, NOS | Adult disease |
C0026654 | A noninflammatory, progressive occlusion of the intracranial CAROTID ARTERIES and the formation of netlike collateral arteries arising from the CIRCLE OF WILLIS. Cerebral angiogram shows the puff-of-smoke (moyamoya) collaterals at the base of the brain. It is characterized by endothelial HYPERPLASIA and FIBROSIS with thickening of arterial walls. This disease primarily affects children but can also occur in adults. | moya moya disease|Progressive intracranial arterial occlusion|Progressive Intracranial Occlusive Arteropathy (Moyamoya)|CEREBROVASCULAR MOYAMOYA DISEASE|Progressive intracranial arterial occlusion (disorder)|moyamoya syndrome|Moyamoya Syndrome|Moyamoya disease (disorder)|Moya-Moya Disease|disease moya moya|moya disease|Moyamoya Disease|Cerebrovascular Moyamoya Disease|Disease, Moya-Moya|Progressive intracranial arterial occlusion syndrome|disease moyamoya|moya-moya disease|Moyamoya disease|Moyamoya syndrome|moyamoya|Moyamoya|Moya Moya Disease|MOYAMOYA DISEASE|MOYAMOYA|moyamoya disease | Moyamoya Disease |
C0260860 | null | General medical examination|Health checkup|Unspecified general medical examination | Encounter due to Unspecified general medical examination |
C1278938 | null | Entire anterior communicating artery|Entire anterior communicating artery (body structure) | Entire anterior communicating artery |
C0023630 | Study of the principles and practices of library administration and services. | Science, Library|Library science|Library Science|Library Sciences|Sciences, Library | Library Science |
C0023630 | Study of the principles and practices of library administration and services. | Science, Library|Library science|Library Science|Library Sciences|Sciences, Library | Library Science |
C0034800 | Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. | Cell receptors|Receptor, Cell Surface|cell surface receptor|Cell Surface Receptors|Cell Surface Receptor | Receptors, Cell Surface |
C0010206 | A substance used to make drugs that prevent and treat blood clots in blood vessels and treat certain heart conditions. Coumarin is taken from certain plants and can also be made in the laboratory. It is a type of anticoagulant. | Coumarin-containing product|Tonka bean camphor|1,2-Benzopyrone|Coumaric anhydride|coumarin|Product containing coumarin (product)|Coumarin|Coumarinic anhydride (substance)|tonka bean camphor|chromen-2-one|2H-1-benzopyran-2-one|Coumarin (substance)|1,2-benzopyrone|2H-1-Benzopyran-2-one|cumarin|COUMARIN|Coumarinic anhydride|Coumarin anticoagulant (substance)|Coumarin anticoagulant|Chromen-2-one|Cumarin|Tonka Bean Camphor|5,6-benzo-alpha-pyrone|alpha benzopyrone | coumarin |
C0162713 | Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. | Photosensitizing agent|photosensitising agent|agents photosensitising|Photosensitizing Agent|Photosensitizer|Photosensitizers|photosensitizing agent|photosensitizer|Photosensitizing agent (product)|photosensitizers|Photosensitising agent|Agents, Photosensitizing | Photosensitizing Agents |
C0729236 | null | Photofrin|photofrin | Photofrin |
C0008266 | Plant cell inclusion bodies that contain the photosynthetic pigment CHLOROPHYLL, which is associated with the membrane of THYLAKOIDS. Chloroplasts occur in cells of leaves and young stems of plants. They are also found in some forms of PHYTOPLANKTON such as HAPTOPHYTA; DINOFLAGELLATES; DIATOMS; and CRYPTOPHYTA. | chloroplasts|Chloroplasts|chloroplast|Chloroplast | Chloroplasts |
C0012531 | Used as an indicator in titrating iron and for the colorimetric determination of chromium and the detection of cadmium, mercury, magnesium, aldehydes, and emetine. | Carbonic dihydrazide, 2,2'-diphenyl-|1,5-Diphenylcarbazide|S-Diphenylcarbazide|S Diphenylcarbazide|1,5 Diphenylcarbazide | Diphenylcarbazide |
C0041625 | That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants. | Ultraviolet Rays|Ultraviolet Ray|UV Radiation|rays ultraviolet|ultraviolet light|Ultraviolet Radiation|Ray, Actinic|UVR - Ultraviolet radiation|Actinic Rays|UV|ray uv|Radiation, UV|Ultra-Violet Rays|Sun/Ultra-Violet Rays|Light, Ultraviolet|UV radiation|UV Light|Ultraviolet radiation (physical force)|UVL - Ultraviolet light|Ultra Violet Rays|radiation ultraviolet|Actinic Ray|Ultraviolet light|ultraviolet rays|rays uv|Ray, Ultraviolet|Ray, Ultra-Violet|ultraviolet radiation|Ultraviolet Light|light ultraviolet|Light, UV|Ultraviolet radiation|uv rays|UV rays|Ultra-Violet Ray | Ultraviolet Rays |
C0005248 | null | beta Lactoglobulin|beta lactoglobulin|Beta-lactoglobulin (substance)|beta-Lactoglobulin|Beta-lactoglobulin | beta Lactoglobulin |
C0039485 | Lower lateral part of the cerebral hemisphere responsible for auditory, olfactory, and semantic processing. It is located inferior to the lateral fissure and anterior to the OCCIPITAL LOBE. | TEMPORAL LOBE|Temporal Cortices|Temporal region|Temporal lobe structure|Lobus temporalis|temporal lobe/cortex|temporal lobes|temporal cortex|Temporal Regions|Cortex, Temporal|temporal region|Temporal Lobes|Region, Temporal|Temporal lobe structure (body structure)|Temporal Cortex|temporal lobe|Temporal lobes|Cortices, Temporal|Lobes, Temporal|Temporal lobe|Regions, Temporal|Temporal cortex|TEMPORAL LOBES|Lobe, Temporal|Temporal Lobe|Temporal lobe, NOS|Temporal Region | Temporal Lobe |
C0376335 | A noninvasive tool used to observe functioning in the brain or other organs by detecting changes in chemical composition, blood flow, or both. | fmri|functional magnetic resonance imaging|Functional MRI|Functional Magnetic Resonance Imaging|MRI, Functional|functional MRI|Magnetic Resonance Imaging, Functional|FUNCTIONAL MRI|Functional MRIs|fMRI|MRI functional|MRIs, Functional | fMRI |
C0034348 | ATP:pyruvate 2-O-phosphotransferase. A phosphotransferase that catalyzes reversibly the phosphorylation of pyruvate to phosphoenolpyruvate in the presence of ATP. It has four isozymes (L, R, M1, and M2). Deficiency of the enzyme results in hemolytic anemia. EC 2.7.1.40. | ATP:Pyruvate 2-O-Phosphotransferase|Pyruvate Kinase (Phosphorylating)|pyruvate kinase|Pyruvic Kinase|Pyruvate Kinase|Pyruvate kinase (substance)|phosphoenol transphosphorylase|PK|Phosphoenolpyruvate kinase|Fluorokinase (Phosphorylating)|Phosphoenolpyruvate Kinase|Phosphoenol transphosphorylase|phosphoenolpyruvate kinase|Fluorokinase|EC 2.7.1.40|kinase pyruvate|Pyruvate kinase|PK - Pyruvate kinase|Pyruvate Phosphotransferase|Phosphoenol Transphosphorylase | Pyruvate Kinase |
C0057817 | null | dianate | dicamba dimethylamine |
C0163338 | A phosphorus-oxygen lyase found primarily in BACTERIA. The enzyme catalyzes the cleavage of a phosphoester linkage in 1-phosphatidyl-1D-myo-inositol to form 1D-myo-inositol 1,2-cyclic phosphate and diacylglycerol. The enzyme was formerly classified as a phosphoric diester hydrolase (EC 3.1.4.10) and is often referred to as a TYPE C PHOSPHOLIPASES. However it is now known that a cyclic phosphate is the final product of this enzyme and that water does not enter into the reaction. | Monophosphatidylinositol Phosphodiesterase|Phosphodiesterase, Monophosphatidylinositol|1-phosphatidylinositol phosphodiesterase|Phosphatidylinositol Diacylglycerol-Lyase|Diacylglycerol-Lyase, Phosphatidylinositol|Phosphatidylinositol Diacylglycerol Lyase|Monophosphatidylinositol phosphodiesterase|1-phosphatidylinositol phosphodiesterase (substance)|1 Phosphatidylinositol Phosphodiesterase|Phosphodiesterase, 1-Phosphatidylinositol|1-Phosphatidylinositol phosphodiesterase|1-Phosphatidylinositol Phosphodiesterase | 1-Phosphatidylinositol phosphodiesterase |
C0369241 | A very large group of microscopic fungi that live on plant or animal matter. Most are filamentous organisms and produce spores that can be air-, water-, or insect-borne. | Filamentous fungus|filamentous fungi|Mold, NOS|Mold (organism)|Fungi, Filamentous|mold|Filamentous Fungi|Mould|MOLD|filamentous fungus|Mould, NOS|Molds|mold [fungus]|Filamentous Fungus|Filamentous fungus (organism)|molds|Mold|Fungus, Filamentous | Filamentous fungus |
C0246719 | null | Risedronate|RISE|1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate|Risedronsäure|Risedronate (substance)|2-(3-pyridinyl)-1-hydroxyethylidenebisphosphonate|RISEDRONATE|2-(3-pyridinyl)-1-hydroxyethylidene-bisphosphonate|risedronate | risedronate |
C0456107 | null | meningitis neonatal|Neonatal meningitis (disorder)|neonatal meningitis | Neonatal meningitis |
C0003708 | Acute or chronic inflammation of the arachnoid membrane of the meninges most often involving the spinal cord or base of the brain. This term generally refers to a persistent inflammatory process characterized by thickening of the ARACHNOID membrane and dural adhesions. Associated conditions include prior surgery, infections, trauma, SUBARACHNOID HEMORRHAGE, and chemical irritation. Clinical features vary with the site of inflammation, but include cranial neuropathies, radiculopathies, and myelopathies. (From Joynt, Clinical Neurology, 1997, Ch48, p25) | Inflammations, Arachnoid Membrane|Arachnoid Membrane Inflammation|Arachnoiditis, NOS|Inflammation, Arachnoid Membrane|arachnoiditis|arachnitis|Arachnoid Membrane Inflammations|Arachnoiditis (disorder)|ARACHNOIDITIS|Arachnoiditis|Arachnoiditides | Arachnoiditis |
C0020944 | The restriction of the MOVEMENT of whole or part of the body by physical means (RESTRAINT, PHYSICAL) or chemically by ANALGESIA, or the use of TRANQUILIZING AGENTS or NEUROMUSCULAR NONDEPOLARIZING AGENTS. It includes experimental protocols used to evaluate the physiologic effects of immobility. | immobilization of body part|Immobilisation - action|Immobilization|Immobilization Technique|Immobilization - action|orthopedic freezing|Immobilization - action (qualifier value)|immobilization|immobilisations|Immobilisation|immobilisation | Immobilization |
C1479975 | null | null | Laeonereis acuta |
C0036002 | Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed) | SAMe|S-Adenosyl-l-methionine|Ademetionine-containing product|s adenosylmethionine|SAM-e|5'-[(3-Amino-3-carboxypropyl)methylsulfonio]-5'-deoxyadenosine Hydroxide, Inner Salt|SAM|ADEMETIONINE|Adenosine, 5'-((3-amino-3-carboxypropyl)methylsulfonio)-5'-deoxy-, inner salt, (3S)-|ademetionine|Ademetionine|adomet|S-Adenosyl-DL-methionine|S-Adenosyl-L-Methionine|(+-)-5'-((R*)-((R*)-3-Amino-3-carboxypropyl)methylsulfonio)-5'-deoxyadenosine Hydroxide, Inner Salt|S-ADENOSYLMETHIONINE|s-adenosylmethionine|S-Adenosyl-methionine|sam|S Adenosyl L Methionine|S Adenosylmethionine|Product containing ademetionine (medicinal product)|Ademetionine (substance)|s-adenosylmethionine (SAMe)|S-Adenosylmethionine|S adenosylmethionine|S-adenosylmethionine|AdoMet|Methionine, S-adenosyl-, DL- | S-adenosylmethionine |
C0010502 | A cyanide compound which has been used as a fertilizer, defoliant and in many manufacturing processes. It often occurs as the calcium salt, sometimes also referred to as cyanamide. The citrated calcium salt is used in the treatment of alcoholism. | Cyanamide|Carbimide|Cyanamid|CYANAMIDE|cyanamide|carbimide | Cyanamide |
C0373156 | null | null | Radiologic examination, spine, single view, specify level |
C0373156 | null | null | Radiologic examination, spine, single view, specify level |
C0373156 | null | null | Radiologic examination, spine, single view, specify level |
C0042345 | Enlarged and tortuous VEINS. | phlebectasia|VARICES|varices|VEIN VARICOSE|Varix, NOS|varicose veins|Venous varices|varicose vein|Venous ectasia|Phlebectasia|Venous varices (disorder)|Varicose veins NOS|Uneven venous ectasia (morphologic abnormality)|Uneven venous ectasia|Varices|Varicose Veins|VARICOSITY|Varicose Vein|varix|varicosities|Vein, Varicose|VARICOSE VEIN|enlarged tortuous blood vessel|Varicosities|Venous varicosities|Varicose veins|Venous ectasia (morphologic abnormality)|Veins, Varicose|venous ectasia|Varicose vein|Varix|VARICOSE VEINS | Varicosity |
C0034896 | The distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL. | LARGE INTESTINE, RECTUM|Rectum, NOS|rectums|Rectum structure|rectum|Rectums|Rectum structure (body structure)|Hemorrhoidal|Rectal structure|Rectum|RECTUM | Rectum |
C0332448 | To penetrate a tissue or substance. | Infiltrating|Infiltrates|infiltrate|tissue infiltration|Tissue infiltration, NOS|infiltration|Infiltration Of Tissue|Infiltrate|Tissue infiltration|infiltrates|Infiltration (morphologic abnormality)|Infiltrate, NOS|infiltrating|Infiltration|Infiltration, NOS|infiltrated | Infiltration |
C0023290 | A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. | KALA-AZAR|Burdwan fever|Leishmaniasis, visceral|Visceral Leishmaniasis|PONOS|VL - Visceral leishmaniasis|Mediterranean leishmaniasis|Kala Azar|Dumdum fever|Kala-Azar|visceral leishmaniasis|LEISHMANIASIS, VISCERAL|MARD EL BICHA|kala azar|azar kala|FEVER, BURDWAN|Dum Dum fever|Visceral [kala-azar] leishmaniasis|Leishmaniasis visceral|Mard el bicha|leishmaniasis visceral|Infection by Leishmania donovani|Fever, Black|Black Fever|Kala-azar|Indian visceral leishmaniasis|Infection by Leishmania, donovani|kala-azar|Visceral leishmaniasis (disorder)|SIRKARI DISEASE|Visceral leishmaniasis|Dum-dum fever|Infection by visceral leishmaniasis|FEVER, DUMDUM|Sirkari disease | Leishmaniasis, Visceral |
C0085295 | A cytokine produced by a variety of cell types, including T-LYMPHOCYTES; MONOCYTES; DENDRITIC CELLS; and EPITHELIAL CELLS that exerts a variety of effects on immunoregulation and INFLAMMATION. Interleukin-10 combines with itself to form a homodimeric molecule that is the biologically active form of the protein. | IL10|Interleukin 10|CSIF-10|INTERLEUKIN-10|Cytokine formation-inhibiting factor (mouse clone F115 protein moiety reduced)|IL-10 (nonglycosylated)|Interleukin-10|il10|interleukin 10|IL-10|interleukin-10|Cytokine Synthesis Inhibitory Factor|Cytokine synthesis inhibiting factor|CSIF|Interleukin-10 (substance)|il-10|il 10 | interleukin-10 |
C0151611 | Abnormality observed by electroencephalogram (EEG), which is used to record of the brain's spontaneous electrical activity from multiple electrodes placed on the scalp. [HPO:curators] | Electroencephalogram abnormal (finding)|ELECTROENCEPHALOGRAM ABNORMAL|eeg abnormality|Electroencephalogram abnormalities|ABNORMAL ELECTROENCEPHALOGRAM|EEG abnormal|EEG abnormality, NOS|Electroencephalogram abnormal|EEG ABNORMAL|Abnormal electroencephalogram|Abnormal EEG|DISORDER EEG (NOS)|EEG abnormalities|abnormality eeg|abnormal eeg|eeg abnormal|Electroencephalogram (EEG) abnormalities|electroencephalogram abnormal|EEG abnormality | Electroencephalogram abnormal |
C1513300 | Specific assays that measure the migration of cells. They are commonly used to measure the migration of immune cells in response to stimuli and the inhibition of immune cell migration by immunosuppressive factors. | Migration Assays|Assay, Cell Migration|Assays, Cell Migration|Cell Migration Assay|Migration Assay, Cell|Migration Assay|Migration Assays, Cell | Cell Migration Assays |
C0309049 | null | favoring|FAVOR | favor |
C0238876 | null | cadmium exposure|CADMIUM EXPOSURE | CADMIUM EXPOSURE |
C0006632 | An element with atomic symbol Cd, atomic number 48, and atomic weight 112.41. It is a metal and ingestion will lead to CADMIUM POISONING. | Cadmium, NOS|Cd|Cadmium (substance)|Cadmium Metal|cadmium|Cadmium|CADMIUM|cadmium (Cd)|Cd element|Cd - Cadmium | cadmium |
C0043316 | An enzyme that catalyzes the oxidation of XANTHINE in the presence of NAD+ to form URIC ACID and NADH. It acts also on a variety of other purines and aldehydes. | EC 1.1.1.204|Purine Hydroxylase I|Xanthine dehydrogenase|Xanthine dehydrogenase (substance)|Xanthine Oxidoreductase|XDH|Xanthine:NAD+ oxidoreductase|Xanthine Dehydrogenase|XOR|Dehydrogenase, Xanthine|XO|Oxidoreductase, Xanthine|xanthine dehydrogenase|XD|Xanthine Dehydrogenase/Oxidase | Xanthine Dehydrogenase |
C0238074 | Heart disease which occurs as a result of a primary pulmonary disease. Cor pulmonale most often manifests as right ventricular hypertrophy; it can also lead to right ventricular failure. | COR PULMONALE, CHRONIC|Chronic Cor pulmonale NOS|Chronic pulmonary heart disease|Chronic Pulmonary Heart Disease|Chronic pulmonary heart disease, unspecified|Chronic cor pulmonale (disorder)|Chronic cor pulmonale|Chronic pulmonary heart disease, NOS|chronic cor pulmonale|Chronic cardiopulmonary disease|COR - Chronic cor pulmonale|Chronic cor pulmonale, NOS|Chronic pulmonary heart disease (disorder)|Cor Pulmonale | Chronic pulmonary heart disease |
C0815050 | null | adenosine antagonists receptor|adenosine receptor antagonist | adenosine receptor antagonist |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.